PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Pacific Biosciences Of California, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2014 to Q3 2024.
  • Pacific Biosciences Of California, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 273M shares, a 7.03% increase year-over-year.
  • Pacific Biosciences Of California, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 254M shares, a 13% increase from 2022.
  • Pacific Biosciences Of California, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 225M shares, a 10% increase from 2021.
  • Pacific Biosciences Of California, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 204M shares, a 16.7% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 273M +17.9M +7.03% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 272M +22.3M +8.92% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 270M +27.5M +11.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 254M +29.1M +13% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 255M +29.9M +13.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 250M +25.6M +11.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 242M +19.7M +8.88% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 225M +20.4M +10% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 225M +10M +4.65% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 224M +25.9M +13.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 222M +27.5M +14.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 204M +29.2M +16.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 215M +48.3M +28.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 199M +44.4M +28.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 195M +38.9M +25% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 175M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 167M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 154M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 156M +4.58M +3.03% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 151M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q3 2016 92.1M +11.6M +14.5% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-04
Q4 2015 78.3M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-06
Q3 2015 80.5M +9.74M +13.8% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-06
Q2 2015 74.7M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-06
Q1 2015 74.1M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-06
Q3 2014 70.7M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.